Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Isosorbide mononitrate inhibits myocardial fibrosis in diabetic rats by up-regulating exosomal MiR-378

Kaidi Zhao¹, Junyi Zhang¹, Ping Li², Rongqiang Yan¹

¹Department of Cardiology, Qingdao Municipal Hospital, Qingdao, China; ²Department of Interventional Radiography, West Hospital of Qingdao Municipal Hospital, Qingdao, China.

For correspondence:- Rongqiang Yan Email: yrqysc@163.com Tel:+8653282716767

Accepted: 8 May 2022 Published: 30 June 2022

Citation: Zhao K, Zhang J, Li P, Yan R. Isosorbide mononitrate inhibits myocardial fibrosis in diabetic rats by up-regulating exosomal MiR-378. Trop J Pharm Res 2022; 21(6):1227-1235 doi: 10.4314/tjpr.v21i6.14

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of isosorbide mononitrate on diabetic cardiomyopathy (DCM), and the potential mechanism of action.

Methods: The effects of isosorbide mononitrate and isosorbide mononitrate + GW4869 on cardiac function and myocardial fibrosis in DCM rats were determined via hemodynamics, hematoxylin-eosin (H&E) staining and Masson staining. Exosomes were extracted from the serum, and the differential expressions of microribonucleic acids (miRNAs) related to myocardial fibrosis were determined by reverse transcription-polymerase chain reaction (qRT-PCR). Western blotting was performed to determine the effects of isosorbide mononitrate and isosorbide mononitrate + GW4869 on IGF1R/STAT3 signaling pathway.

Results: Isosorbide mononitrate exerted a protective effect against DCM-induced cardiac dysfunction and myocardial fibrosis, while such a protective effect was suppressed by the exosome inhibitor GW4869 (p < 0.05). The expression of miR-378 in exosomes significantly rose in isosorbide mononitrate group. The increased expression of miR-378 in vitro inhibited the proliferation of primary myocardial fibroblasts, and reduced the expression of myocardial fibrosis markers (p < 0.05). Luciferase reporter assay data showed that miR-378 negatively regulated the expression of IGF1R by direct binding to IGF1R mRNA 3'-untranslated region (3'UTR). In primary myocardial fibroblasts, miR-378 mimic significantly reduced the protein expressions of IGF1R, p-STAT3/STAT3 and c-Myc (p < 0.05). Isosorbide mononitrate lowered the protein expressions of IGF1R, p-STAT3/STAT3 and c-Myc, but the inhibitory effect was weakened by the exosome inhibitor, GW4869 (p < 0.05).

Conclusion: Isosorbide mononitrate inhibits myocardial fibrosis in diabetic rats by up-regulating exosomal miR-378, and targeting the axis of STAT3/IGF1R. The results of this study may provide a new insight into the treatment of DCM.

Keywords: Isosorbide mononitrate, Diabetic cardiomyopathy, Myocardial fibrosis, Exosomal miR-378, STAT3 signaling pathway